Jeff Yass’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$280K Sell
72,716
-19,299
-21% -$70.4K ﹤0.01% 11208
2026
Q1
$363K Buy
92,015
+57,821
+169% +$291K ﹤0.01% 10433
2025
Q4
$231K Sell
34,194
-55,255
-62% -$387K ﹤0.01% 10546
2025
Q3
$624K Sell
89,449
-128,328
-59% -$892K ﹤0.01% 8461
2025
Q2
$1.33M Buy
217,777
+4,218
+2% +$28.1K ﹤0.01% 6723
2025
Q1
$1.62M Sell
213,559
-123,466
-37% -$1.03M ﹤0.01% 6013
2024
Q4
$3.24M Buy
337,025
+79,901
+31% +$622K ﹤0.01% 4330
2024
Q3
$1.52M Sell
257,124
-38,990
-13% -$258K ﹤0.01% 5880
2024
Q2
$2.05M Sell
296,114
-331,607
-53% -$2.33M ﹤0.01% 5048
2024
Q1
$4.83M Buy
627,721
+200,381
+47% +$1.61M ﹤0.01% 3686
2023
Q4
$3.75M Buy
427,340
+381,344
+829% +$2.79M ﹤0.01% 4212
2023
Q3
$335K Sell
45,996
-18,191
-28% -$136K ﹤0.01% 9112
2023
Q2
$424K Sell
64,187
-40,122
-38% -$205K ﹤0.01% 8694
2023
Q1
$356K Buy
104,309
+60,497
+138% +$234K ﹤0.01% 9337
2022
Q4
$122K Sell
43,812
-75,562
-63% -$226K ﹤0.01% 10749
2022
Q3
$343K Buy
119,374
+29,133
+32% +$104K ﹤0.01% 9447
2022
Q2
$313K Sell
90,241
-92,740
-51% -$363K ﹤0.01% 9460
2022
Q1
$862K Buy
182,981
+3,610
+2% +$17.7K ﹤0.01% 7516
2021
Q4
$1.08M Sell
179,371
-187,816
-51% -$1.3M ﹤0.01% 7082
2021
Q3
$2.23M Buy
367,187
+241,300
+192% +$2.72M ﹤0.01% 5598
2021
Q2
$1.57M Sell
125,887
-456,603
-78% -$4.95M ﹤0.01% 6505
2021
Q1
$6M Buy
582,490
+514,560
+757% +$4.97M ﹤0.01% 3575
2020
Q4
$617K Buy
+67,930
New +$489K ﹤0.01% 7825
2018
Q3
Sell
-192,200
Closed -$869K 9825
2018
Q2
$1.23M Buy
+192,200
New +$1.37M ﹤0.01% 4918
2017
Q1
Sell
-59,712
Closed -$504K 9536
2016
Q4
$529K Buy
+59,712
New +$537K ﹤0.01% 6855
2016
Q2
Sell
-111,054
Closed -$864K 9015
2016
Q1
$971K Sell
111,054
-56,521
-34% -$470K ﹤0.01% 5142
2015
Q4
$1.57M Sell
167,575
-141,308
-46% -$1.22M ﹤0.01% 4533
2015
Q3
$2.98M Buy
308,883
+94,391
+44% +$996K ﹤0.01% 3507
2015
Q2
$2.49M Buy
214,492
+29,493
+16% +$303K ﹤0.01% 4237
2015
Q1
$1.92M Buy
184,999
+88,029
+91% +$824K ﹤0.01% 4393
2014
Q4
$1.12M Buy
96,970
+82,711
+580% +$817K ﹤0.01% 5632
2014
Q3
$102K Sell
14,259
-52,394
-79% -$365K ﹤0.01% 9061
2014
Q2
$473K Sell
66,653
-9,826
-13% -$57.5K ﹤0.01% 7578
2014
Q1
$469K Sell
76,479
-23,863
-24% -$175K ﹤0.01% 6837
2013
Q4
$877K Buy
+100,342
New +$614K ﹤0.01% 5733
2013
Q3
Sell
-23,258
Closed -$128K 8617
2013
Q2
$164K Buy
+23,258
New +$163K ﹤0.01% 7575

Other funds holding MDXG

Jeff Yass's MDXG Position: Q2 2026 in Review

Jeff Yass reduced its MiMedx Group (MDXG) stake by 21% in Q2 2026, selling an estimated $70.4K and leaving 72,716 shares worth $280K. The position accounts for ﹤0.01% of the portfolio, ranked #11208.

Jeff Yass first reported a position in MDXG in Q2 2013 and has held it in 36 quarters since. The position peaked at $6M in Q1 2021. 225 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Jeff Yass held 72,716 shares of MiMedx Group worth $280K as of Q2 2026.
  • Jeff Yass sold 19,299 MiMedx Group shares in Q2 2026, an estimated $70.4K.
  • MiMedx Group made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #11208 holding.
  • Jeff Yass first reported a position in MiMedx Group in Q2 2013 and has held it in 36 quarters since.
  • Jeff Yass's MiMedx Group position peaked at $6M in Q1 2021.
  • 225 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.